Ignite Creation Date:
2024-07-17 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06484062
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-29
Brief Title:
Testing the Anti-cancer Drug Cirtuvivint and Its Combination With ASTX727 and ASTX727 With Venetoclax to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
| Myelodysplastic Syndrome |
| Recurrent Acute Myeloid Leukemia |
| Recurrent Myelodysplastic Syndrome |
| Refractory Acute Myeloid Leukemia |
| Refractory Myelodysplastic Syndrome |
Keywords: